Company: MYGN
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0000899923-25-000086
Chunk: 15

Company: MYRIAD GENETICS INC
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 1
Chunk 15
---
(1.4)Other assets0.7 0.7 Accounts payable3.6 9.4 Accrued liabilities(29.2)(20.1)Net cash used in operating activities(29.9)(16.0)CASH FLOWS FROM INVESTING ACTIVITIES:Capital expenditures(8.1)(11.9)Capitalization of intangible assets(7.1)(5.6)Proceeds from maturities and sales of marketable investment securities— 4.0 Net cash used in investing activities(15.2)(13.5)CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from common stock issued under stock-based compensation plans2.7 3.0 Payment of tax withheld for common stock issued under stock-based compensation plans(5.8)(9.2)Proceeds from revolving credit facility40.0 80.0 Repayment of revolving credit facility(20.5)(80.0)Payment on finance leases(0.2)(0.2)Net cash provided by (used in) financing activities16.2 (6.4)Effect of foreign exchange rates on cash, cash equivalents, and restricted cash0.7 (1.5)Change in cash and cash equivalents classified as held for sale— (2.3)Net decrease in cash, cash equivalents, and restricted cash(28.2)(39.7)Cash, cash equivalents, and restricted cash at beginning of the period111.9 140.9 Cash, cash equivalents, and restricted cash at end of the period$83.7 $101.2 

See accompanying notes to Condensed Consolidated Financial Statements.

8

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.BASIS OF PRESENTATION

Myriad Genetics, Inc. (together with its subsidiaries, the “Company” or “Myriad”) is a leading molecular diagnostic testing and precision company dedicated to advancing health and well-being for all. Myriad develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower health care costs. Myriad provides insights that help people take control of their health and enable healthcare providers to better detect, treat, and prevent disease. The Company’s principal executive office is located in Salt Lake City, Utah.The accompanying Cond